Leukemia cutis in a patient with chronic myelomonocytic leukemia

J Dtsch Dermatol Ges. 2018 Jan;16(1):81-83. doi: 10.1111/ddg.13398. Epub 2017 Dec 30.

Authors

Anna Claßen¹, Julia Kitz², Christina Perske², Tobias Overbeck³, Hans Peter Bertsch¹, Michael P Schön¹, Undine Lippert¹

Affiliations

¹ Department of Dermatology, Venereology, and Allergology, University Medicine Göttingen, Göttingen, Germany.
² Institute for Pathology, University Medicine Göttingen, Göttingen, Germany.
³ Department of Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany.

PMID: 29288601
DOI: 10.1111/ddg.13398

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antimetabolites, Antineoplastic / therapeutic use
Azacitidine / therapeutic use
Blast Crisis / diagnosis
Blast Crisis / drug therapy
Blast Crisis / pathology
Diagnosis, Differential
Humans
Leukemia, Myelomonocytic, Chronic / diagnosis*
Leukemia, Myelomonocytic, Chronic / drug therapy
Leukemia, Myelomonocytic, Chronic / pathology*
Leukemic Infiltration / diagnosis*
Leukemic Infiltration / drug therapy
Leukemic Infiltration / pathology*
Male
Skin / pathology*

Substances

Antimetabolites, Antineoplastic
Azacitidine